Antimitotic Agents: all 5,052 studies that test it

Page 16 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.

• Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid CancerTerminatedNCT00507429Phase 2/3Results posted
• MPC-004 for the Treatment of an Acute Gout FlareCompletedNCT00506883Phase 3Results posted
• Gleevec/Taxol for Patients With Uterine Papillary Serous CarcinomaTerminatedNCT00506779Phase 1/2Results posted
• Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial CancerCompletedNCT00506155Phase 2Results posted
• Safety and Efficacy of Marqibo in Metastatic Malignant Uveal MelanomaCompletedNCT00506142Phase 2Results posted
• Biochemotherapy With Temozolomide for Metastatic MelanomaTerminatedNCT00505635Phase 2Results posted
• Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum CarcinomaCompletedNCT00504257Phase 2Results posted
• Abraxane, Avastin, and Gemcitabine as First-Line Therapy for Patients With Metastatic Breast CancerCompletedNCT00503906Phase 2Results posted
• Phase II Neoadjuvant Trial of Trastuzumab in Combination With Dose-Dense ABI-007 (Abraxane™)CompletedNCT00503750Phase 2Results posted
• Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the UterusCompletedNCT00502203Phase 2Results posted
• Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate CancerCompletedNCT00500110Phase 2Results posted
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT00499252Phase 2Results posted
• NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast CancerCompletedNCT00499122Phase 2Results posted
• Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLCCompletedNCT00499109Phase 3Results posted
• Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)CompletedNCT00499083Phase 2Results posted
• E3-Hormone Refractory Prostrate Cancer Taxotere CombinationCompletedNCT00498797Phase 2Results posted
• ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain MetastasesTerminatedNCT00496379Phase 2Results posted
• Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00495170Phase 2Results posted
• Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic LeukemiaCompletedNCT00495079Phase 2Results posted
• Ofatumumab (Humax-CD20) With CHOP (Cyclophosphamide,Doxorubicin, Vincristine, Predisolone) in Follicular Lymphoma (FL) PatientsCompletedNCT00494780Phase 2Results posted
• Adj TC + Herceptin Early Stage Breast CancerCompletedNCT00493649Phase 2Results posted
• Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By SurgeryTerminatedNCT00493025Phase 2Results posted
• A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced and/or Metastatic Breast CancerCompletedNCT00490646Phase 2Results posted
• Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC)CompletedNCT00488982Phase 2Results posted
• Phase I/II, Open-label, Multi-center, Two Part Dose-escalation, Safety, Pharmacokinetics (PK) and Efficacy Study of AZD4877 in Patients With Acute Myelogenous Leukemia (AML)TerminatedNCT00486265Phase 1Results posted
• Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell CancerCompletedNCT00485485Phase 2Results posted
• Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast CancerCompletedNCT00482391Phase 2Results posted
• Docetaxel in Treating Patients With Relapsed Prostate CancerTerminatedNCT00482274Phase 2Results posted
• Salvage Radiation Therapy and Taxotere for PSA Failure After Radical ProstatectomyTerminatedNCT00480857Phase 2Results posted
• A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent GliomaTerminatedNCT00479765Phase 1/2Results posted
• Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast CancerCompletedNCT00479674Phase 2Results posted
• Randomized Customized Adjuvant Chemotherapy (GECP-SCAT)CompletedNCT00478699Phase 3Results posted
• Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney FunctionCompletedNCT00478361Phase 2Results posted
• A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to BrainTerminatedNCT00476827Phase 2Results posted
• ALL Adult Consortium Trial: Adult ALL TrialCompletedNCT00476190Phase 2Results posted
• ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyTerminatedNCT00471718Phase 1/2Results posted
• Abraxane and Alimta in Advanced Solid TumorsTerminatedNCT00470548Phase 1/2Results posted
• Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell TumorsCompletedNCT00470366Phase 2Results posted
• Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast CancerCompletedNCT00470301Phase 1/2Results posted
• Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell TumorsCompletedNCT00467051Phase 2Results posted
• Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous ChemotherapyCompletedNCT00466960Phase 2Results posted
• A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer PatientsCompletedNCT00466440Phase 2Results posted
• Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast CancerCompletedNCT00464646Phase 2Results posted
• Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II StudyCompletedNCT00462423Phase 2Results posted
• The Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate CancerCompletedNCT00459186Phase 1/2Results posted
• Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by SurgeryTerminatedNCT00459121Phase 2Results posted
• Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate CancerCompletedNCT00456989Phase 1/2Results posted
• First Line Therapy for Patients With Metastatic Breast CancerTerminatedNCT00456846Phase 2Results posted
• Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast CancerCompletedNCT00455533Phase 2Results posted
• Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid TumorCompletedNCT00454649Phase 1Results posted
• Study of Abraxane and Carboplatin to Treat Small Cell Lung CancerTerminatedNCT00454324Phase 2Results posted
• Epothilone B in Treating Patients With CNS Metastases From Breast CancerCompletedNCT00450866Phase 2Results posted
• R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell LymphomaCompletedNCT00450801Phase 2Results posted
• Combination Chemotherapy in Treating Patients With Previously Untreated Stage II or Stage III Esophageal Cancer That Can Be Removed By SurgeryCompletedNCT00448760Phase 2Results posted
• Combination Chemotherapy as First-Line Therapy in Treating Patients With Stage IV Gastric Cancer That Cannot Be Removed By SurgeryTerminatedNCT00448682Phase 2Results posted
• Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach CancerCompletedNCT00446290Phase 1Results posted
• A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast CancerCompletedNCT00445458Phase 1/2Results posted
• Doxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast CancerCompletedNCT00442260Phase 1/2Results posted
• Cetuximab, Paclitaxel, Carboplatin & Radiation for Esoph, Gastroesoph & Gastric CancerCompletedNCT00439608Phase 2Results posted
• ABT-751 With Chemotherapy for Relapsed Pediatric ALLTerminatedNCT00439296Phase 1/2Results posted
• Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate CancerCompletedNCT00439270Phase 1/2Results posted
• ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous TreatmentCompletedNCT00436852Phase 2Results posted
• Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By SurgeryCompletedNCT00436566Phase 2Results posted
• A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.CompletedNCT00432562Phase 1Results posted
• Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer PatientsCompletedNCT00432172Phase 2Results posted
• Autologous Peripheral Blood Stem Cell Transplant for Germ Cell TumorsCompletedNCT00432094Phase 2Results posted
• Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate CancerActive, not recruitingNCT00430183Phase 3Results posted
• Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) PatientsCompletedNCT00428922Phase 2Results posted
• Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast CancerCompletedNCT00426556Phase 1Results posted
• Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic CancerTerminatedNCT00426127Phase 2Results posted
• Bortezomib and Docetaxel in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00425750Phase 2Results posted
• Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to CisplatinCompletedNCT00423852Phase 1/2Results posted
• A Phase I Study of Oral Ixabepilone in Subjects With Advanced CancerCompletedNCT00422097Phase 1Results posted
• A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse TreatmentCompletedNCT00421889Phase 1/2Results posted
• XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate CancerCompletedNCT00417079Phase 3Results posted
• Neo-adjuvant Chemotherapy in Locally Advanced Gastric CancerCompletedNCT00414271Phase 2Results posted
• E7389 Administered as an IV Bolus Infusion Day 1 and Day 8 Every 3 Weeks in Pre-Treated Patients With Advanced and/or Metastatic Soft Tissue SarcomaCompletedNCT00413192Phase 2Results posted
• Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00408460Phase 2Results posted
• Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal CancerTerminatedNCT00408070Phase 2Results posted
• Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic LymphomaCompletedNCT00408005Phase 3Results posted
• Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With SurgeryCompletedNCT00407888Phase 2Results posted
• Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal CancerCompletedNCT00407563Phase 2Results posted
• Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or Recurrent Non-Small Cell Lung CancerTerminatedNCT00406276Phase 1/2Results posted
• Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast CancerCompletedNCT00404066Phase 2Results posted
• Phase 2 Study of Gemzar, Taxol & Avastin Combination as 1st Line Treatment for Metastatic Breast CancerCompletedNCT00403130Phase 2Results posted
• Bevacizumab + CHOP-Rituximab in Untreated Mantle Cell LymphomaCompletedNCT00401817Phase 2Results posted
• E7389 in Treating Patients With Recurrent or Progressive Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00400829Phase 2Results posted
• Study of Induction Docetaxel, Cisplatin and 5-FluorouracilTerminatedNCT00400205Phase 2Results posted
• Gemcitabine Plus Albumin-bound Paclitaxel In Patients With Advanced Metastatic Pancreatic CancerCompletedNCT00398086Phase 1/2Results posted
• Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric CancerCompletedNCT00394433Phase 2Results posted
• Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast CancerCompletedNCT00394251Phase 2Results posted
• ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast CancerCompletedNCT00394082Phase 2Results posted
• Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast CancerCompletedNCT00392392Phase 2Results posted
• Docetaxel and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsCompletedNCT00390429Phase 1/2Results posted
• Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal AdenocarcinomaCompletedNCT00390416Phase 2Results posted
• Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's LymphomaCompletedNCT00389818Phase 2Results posted
• E7389 Versus Treatment of Physician's Choice in Patients With Locally Recurrent or Metastatic Breast CancerCompletedNCT00388726Phase 3Results posted
• Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer PatientsCompletedNCT00383760Phase 2Results posted
• A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic CancerCompletedNCT00383149Phase 2Results posted
• Docetaxel and Oxaliplatin in Gastric CancerCompletedNCT00382720Phase 2Results posted

← Antimitotic Agents overview